Merit Medical Systems Inc (MMSI) Income Statement
An income statement shows a company's revenue, expenses, and profit over a reporting period.
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States, China, Japan, Germany, France, the United Kingdom, and internationally.
Total Revenue Chart for Merit Medical Systems Inc
Merit Medical Systems Inc (MMSI) revenue for FY2025 was USD 1.5B, a 11.7% change from FY2024. Merit Medical Systems Inc's revenue grew from USD 1.4M in 1989 to USD 1.5B in 2025 (108095.0% over 36 years). Earnings per share grew from USD 0.03 in 2000 to USD 1.29 in 2022 (4164.3%). Revenue compound annual growth rate: 5-year CAGR of 9.5%, 10-year CAGR of 10.8%, 20-year CAGR of 11.7%.
Total Revenue (US Dollars)
R&D as % of Revenue
Compare with
Key Stats
- Market Cap
- $5.57B
- Implied Share Price
- $93.30
- Enterprise Value
- $5.58B
- Revenue (TTM)
- $1.58B
- EBITDA
- $338.94M
- Profit Margin
- 9.22%
- Trailing P/E
- 38.40
- Forward P/E
- 18.94
- Price/Book (MRQ)
- 3.10
- Price/Sales (TTM)
- 3.53
- EV/EBITDA
- 15.42
- EV/Revenue
- 3.54
- Dividend Yield
- —
- Book Value
- $28.13
- Free Cash Flow (FY2025)
- $212.53M
- Free Cash Flow Yield
- 3.82%
Snapshot as of 24th October 2026 — not point-in-time controlled, may lag the live market by a few days.